Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Evgen Pharma ( (GB:TCF) ) is now available.
TheraCryf PLC, a non-UK issuer, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights by T and I Limited. The notification indicates that T and I Limited now holds 7.5131% of the voting rights in TheraCryf, marking a notable shift in shareholder influence.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For a thorough assessment of TCF stock, go to TipRanks’ Stock Analysis page.